Profiel
Géraldine Honnet is currently the Chief Medical Officer at Sensorion SA since 2020.
Prior to this, she worked as the Director-Development at Genethon from 2017 to 2020, as a Senior Clinical Manager at Transgene SA from 2007 to 2011, and as a Medical Director at PAREXEL International Corp.
from 2001 to 2005.
Actieve functies van Géraldine Honnet
| Bedrijven | Functie | Begin |
|---|---|---|
| SENSORION | Hoofd Techniek/Wetenschap/O&O | 18-02-2020 |
Eerdere bekende functies van Géraldine Honnet
| Bedrijven | Functie | Einde |
|---|---|---|
Genethon
Genethon BiotechnologyHealth Technology Develops gene therapy products for rare diseases | Corporate Officer/Principal | 01-01-2020 |
| TRANSGENE | Corporate Officer/Principal | 01-04-2011 |
| PAREXEL INTERNATIONAL CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-09-2005 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
PAREXEL International Corp.
PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Transgene SA
Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Sensorion SA
Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
Genethon
Genethon BiotechnologyHealth Technology Develops gene therapy products for rare diseases | Health Technology |
















